financetom
IROQ
financetom
/
Financials
/
IROQ
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
IF Bancorp, Inc.IROQ
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

IF Bancorp, Inc. operates as the savings and loan holding company for Iroquois Federal Savings and Loan Association that provides a range of banking and financial services to individual and corporate clients.

The company offers various deposit accounts, including savings accounts, certificates of deposit, money market accounts, commercial and personal checking accounts, individual retirement accounts, and health savings accounts.

It provides loans comprising one- to four-family residential mortgage loans; multi-family mortgage loans; commercial real estate loans, such as farm loans; home equity lines of credit; commercial business loans; and consumer loans primarily comprising automobile loans, as well as construction loans and land development loans.

In addition, the company sells property and casualty insurance, as well as offers annuities; mutual funds; individual and group retirement plans; life, disability, and health insurance; individual securities; managed accounts; and other financial services.

Further, it invests in securities; and provides ATM, online banking and bill pay, mobile banking, ACH origination, remote deposit capture, and telephone banking services.

IF Bancorp, Inc. was founded in 1883 and is headquartered in Watseka, Illinois.

Latest News >
Arch Capital Renews $1 Billion Share Repurchase Program
Arch Capital Renews $1 Billion Share Repurchase Program
Dec 20, 2024
04:40 PM EST, 12/20/2024 (MT Newswires) -- Arch Capital Group ( ACGL ) said Friday it has renewed its share repurchase authorization of $1.0 billion, which may be effected from time to time in open market or privately negotiated transactions. The company said the new program replaces its existing buyback authorization. ...
Sarepta wins $115.2 million US drug patent verdict from Japan's Nippon Shinyaku
Sarepta wins $115.2 million US drug patent verdict from Japan's Nippon Shinyaku
Dec 20, 2024
Dec 20 - Japanese drugmaker Nippon Shinyaku ( NPNKF ) infringed a Sarepta patent related to its Duchenne muscular dystrophy (DMD) drug Vyondys 53 and must pay $115.2 million in damages, a Delaware jury said on Friday. The jury also rejected competing patent claims by Shinyaku, which had accused Sarepta of violating its patent rights in its DMD drug Viltepso....
Lilly's weight-loss drug Zepbound wins US FDA approval for sleep apnea
Lilly's weight-loss drug Zepbound wins US FDA approval for sleep apnea
Dec 20, 2024
Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's ( LLY ) weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder. The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company said. Sleep...
US FDA declines to approve Lexicon Pharma's add-on diabetes drug
US FDA declines to approve Lexicon Pharma's add-on diabetes drug
Dec 20, 2024
Dec 20 (Reuters) - The U.S. Food and Drug Administration declined to approve Lexicon Pharmaceuticals' ( LXRX ) add-on drug for type 1 diabetes and chronic kidney disease, the company said on Friday. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved